Bio-inspired nanotechnology for drug delivery

Trevor P. Castor, President and CEO, Aphios Corporation

Come learn about how Aphios is developing green, bio-inspired biotechnology and nanotechnology drug delivery platforms to improve the discovery and manufacturing of natural pharmaceuticals and dietary supplements, the delivery anti-cancer compounds (including recombinant proteins and nucleic acids), and the safety of biologics such as monoclonal antibodies.

Dr Trevor CastorTrevor P. Castor, Ph.D., President and Chief Executive Officer, has over 30 years of diversified business experience ranging from management, marketing and finance to technology and business development in the energy, environmental and biopharmaceutical industries. He has had bottom-line experience with several high-tech startups. Dr. Castor graduated from the University of California, Berkeley, with a Ph.D. in Mechanical Engineering and a Master of Science degree in Chemical Engineering. He graduated summa cum laude with a Bachelor of Science degree in Chemical Engineering from the University of Toronto, Toronto, Canada. He studied Business Administration at St. Mary’s College, Brooklyn, NY, and Management, Marketing and Finance at the Harvard University Extension Program, Cambridge, MA. He is the primary author of 36 issued US and international patents and 15 pending patents. Dr. Castor has collaborated with and consulted to several multinational companies including Baxter Healthcare, Bayer AG, Bristol-Myers Squibb, Eli Lilly, General Electric, Novartis AG and the Gillette Company, and financial institutions such as the Bank of New England and the New England Life Insurance Company.

Time & Location: 123 Snell Library, 3:30pm, January 23